Citadel Advisors’s Natus Medical Inc NTUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-11,014
| Closed | -$289K | – | 14790 |
|
|
2022
Q1 | $289K | Sell |
11,014
-7,814
| -42% | -$191K | ﹤0.01% | 10682 |
|
|
2021
Q4 | $447K | Sell |
18,828
-10,106
| -35% | -$249K | ﹤0.01% | 9972 |
|
|
2021
Q3 | $726K | Sell |
28,934
-44,645
| -61% | -$1.14M | ﹤0.01% | 8971 |
|
|
2021
Q2 | $1.91M | Buy |
73,579
+47,378
| +181% | +$1.29M | ﹤0.01% | 6733 |
|
|
2021
Q1 | $671K | Buy |
26,201
+5,452
| +26% | +$140K | ﹤0.01% | 9038 |
|
|
2020
Q4 | $416K | Sell |
20,749
-12,534
| -38% | -$245K | ﹤0.01% | 8485 |
|
|
2020
Q3 | $570K | Buy |
+33,283
| New | +$629K | ﹤0.01% | 7067 |
|
|
2020
Q2 | – | Sell |
-106,454
| Closed | -$2.44M | – | 10761 |
|
|
2020
Q1 | $2.46M | Buy |
106,454
+72,035
| +209% | +$2.09M | ﹤0.01% | 3811 |
|
|
2019
Q4 | $1.14M | Buy |
+34,419
| New | +$1.1M | ﹤0.01% | 5363 |
|
|
2019
Q3 | – | Sell |
-112,461
| Closed | -$3.28M | – | 9979 |
|
|
2019
Q2 | $2.89M | Sell |
112,461
-22,740
| -17% | -$579K | ﹤0.01% | 3917 |
|
|
2019
Q1 | $3.43M | Buy |
135,201
+121,869
| +914% | +$3.64M | ﹤0.01% | 3536 |
|
|
2018
Q4 | $454K | Sell |
13,332
-68,629
| -84% | -$2.23M | ﹤0.01% | 6546 |
|
|
2018
Q3 | $2.92M | Buy |
81,961
+74,593
| +1,012% | +$2.63M | ﹤0.01% | 3775 |
|
|
2018
Q2 | $254K | Sell |
7,368
-35,923
| -83% | -$1.26M | ﹤0.01% | 7500 |
|
|
2018
Q1 | $1.46M | Buy |
+43,291
| New | +$1.37M | ﹤0.01% | 4222 |
|
|
2017
Q4 | – | Sell |
-5,452
| Closed | -$218K | – | 8606 |
|
|
2017
Q3 | $204K | Sell |
5,452
-205,629
| -97% | -$7.26M | ﹤0.01% | 6670 |
|
|
2017
Q2 | $7.87M | Buy |
211,081
+15,821
| +8% | +$572K | 0.01% | 1651 |
|
|
2017
Q1 | $7.66M | Sell |
195,260
-22,872
| -10% | -$858K | 0.01% | 1641 |
|
|
2016
Q4 | $7.59M | Buy |
218,132
+142,785
| +190% | +$5.61M | 0.01% | 1598 |
|
|
2016
Q3 | $2.96M | Buy |
75,347
+8,292
| +12% | +$331K | ﹤0.01% | 2511 |
|
|
2016
Q2 | $2.54M | Sell |
67,055
-3,954
| -6% | -$132K | ﹤0.01% | 2488 |
|
|
2016
Q1 | $2.73M | Buy |
71,009
+33,175
| +88% | +$1.24M | ﹤0.01% | 2341 |
|
|
2015
Q4 | $1.82M | Sell |
37,834
-105,157
| -74% | -$4.87M | ﹤0.01% | 2837 |
|
|
2015
Q3 | $5.64M | Sell |
142,991
-4,725
| -3% | -$201K | 0.01% | 1825 |
|
|
2015
Q2 | $6.29M | Buy |
147,716
+81,634
| +124% | +$3.25M | 0.01% | 1853 |
|
|
2015
Q1 | $2.61M | Buy |
66,082
+65,838
| +26,983% | +$2.43M | ﹤0.01% | 2737 |
|
|
2014
Q4 | $9K | Sell |
244
-27,878
| -99% | -$937K | ﹤0.01% | 8162 |
|
|
2014
Q3 | $830K | Buy |
28,122
+2,845
| +11% | +$78.5K | ﹤0.01% | 3947 |
|
|
2014
Q2 | $635K | Buy |
25,277
+12,962
| +105% | +$320K | ﹤0.01% | 4090 |
|
|
2014
Q1 | $318K | Sell |
12,315
-40,616
| -77% | -$1.02M | ﹤0.01% | 4957 |
|
|
2013
Q4 | $1.19M | Buy |
52,931
+23,880
| +82% | +$461K | ﹤0.01% | 3051 |
|
|
2013
Q3 | $412K | Sell |
29,051
-22,915
| -44% | -$306K | ﹤0.01% | 4020 |
|
|
2013
Q2 | $709K | Buy |
+51,966
| New | +$708K | ﹤0.01% | 3501 |
|
Other funds holding NTUS
MAM
Citadel Advisors's NTUS Position: Q2 2022 in Review
Citadel Advisors sold out of Natus Medical Inc (NTUS) in Q2 2022, closing a stake of 11,014 shares — an estimated $289K sold.
Citadel Advisors first reported a position in NTUS in Q2 2013 and held it in 33 quarters. The position peaked at $7.87M in Q2 2017. 186 funds tracked by Wall St. Rank hold NTUS as of Q2 2022.
- Citadel Advisors reported no remaining Natus Medical Inc position as of Q2 2022 after selling out during the quarter.
- Citadel Advisors sold 11,014 Natus Medical Inc shares in Q2 2022, an estimated $289K.
- Citadel Advisors first reported a position in Natus Medical Inc in Q2 2013 and held it in 33 quarters.
- Citadel Advisors's Natus Medical Inc position peaked at $7.87M in Q2 2017.
- 186 funds tracked by Wall St. Rank held Natus Medical Inc as of Q2 2022.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.